Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Atorvastatin prevents autoimmune disease by interfering with Ras and Rho GTPase prenylation

April 19, 2005

EGCG exerts neuroprotective and antiinflammatory actions in murine EAE

April 19, 2005

New indication approved for Hyzaar

April 18, 2005

Novel analgesic drugs presented in recent patent literature

April 18, 2005

YM BioSciences to acquire Delex Therapeutics

April 18, 2005

Good analgesic efficacy found with lamotrigine plus sertraline in neuropathic pain

April 18, 2005

Raloxifene lowers the risk of cognitive impairment in postmenopausal women

April 15, 2005

NGP-1-01, a promising lead for novel neuroprotective agents

April 15, 2005

OMS-103HP enters phase III

April 15, 2005

Memory extends timeline for safety and tolerability study of MEM-1003

April 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...